Home › Migraine › Arkansas
Migraine clinical trials in Arkansas
3 studies for Migraine are looking for participants at sites in Arkansas.
Cities in Arkansas
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- Preferred Research Partners /ID# 270389, Little Rock
RecruitingPhase 3
Ages 12 to 17 · All sexes · Updated Sep 22, 2026 · NCT06810505Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- HealthStar Research Glenwood /ID# 275303, Glenwood
- HealthStar Research of Hot Springs /ID# 273256, Hot Springs
- Preferred Research Partners /ID# 230725, Little Rock
RecruitingPhase 3
Ages 6 to 17 · All sexes · Updated Sep 14, 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Arkansas Clinical Research, Little Rock
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 20, 2026 · NCT07645924From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.